Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02947646
Other study ID # STUDY00004892
Secondary ID R41HD088139
Status Completed
Phase N/A
First received
Last updated
Start date November 2016
Est. completion date December 2016

Study information

Verified date May 2022
Source Actuated Medical, Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a pilot, randomized, safety and efficacy study of an investigational device (i.e. BabyGentleStick™; BGS, Actuated Medical, Inc). The primary study objectives are to obtain subject feedback, assess device performance; and ascertain potential harm in healthy adult volunteers.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date December 2016
Est. primary completion date December 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 29 Years
Eligibility Inclusion Criteria: - Healthy adult volunteers 18-29 years of age. - Fluent in written and spoken English - Sex: male or female Exclusion Criteria: - Pregnant women - Cognitive impairment - Prisoner - Individuals with known hematologic conditions or bleeding disorders - Individuals with immune disorders where a finger lance puts them at risk for infection.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
BabyGentleStick™ ON
experimental intervention
BabyGentleStick™ OFF
active comparator

Locations

Country Name City State
United States Penn State Milton S. Hershey Medical Center Hershey Pennsylvania

Sponsors (3)

Lead Sponsor Collaborator
Actuated Medical, Inc. Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Milton S. Hershey Medical Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of Adverse Events Subjects will receive a follow-up phone call 24 hours post-intervention to monitor adverse events. 24 hours after the intervention is received for each subject
Secondary Reduced Pain Response Relative Likert pain scale from 1 to 10, with 0 being no pain and 10 being extreme pain. 5 minutes